Australia markets closed

Biohaven Ltd. (BHVN)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
42.16-1.87 (-4.25%)
At close: 04:00PM EDT
42.20 +0.04 (+0.09%)
Pre-market: 04:00AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.45B
Enterprise value 3.10B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)8.06
Enterprise value/revenue N/A
Enterprise value/EBITDA -7.22

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3194.00%
S&P500 52-week change 321.23%
52-week high 362.21
52-week low 312.35
50-day moving average 351.83
200-day moving average 334.81

Share statistics

Avg vol (3-month) 31.24M
Avg vol (10-day) 31.44M
Shares outstanding 581.81M
Implied shares outstanding 683.53M
Float 865.85M
% held by insiders 113.63%
% held by institutions 189.90%
Shares short (28 Mar 2024) 48.57M
Short ratio (28 Mar 2024) 45.16
Short % of float (28 Mar 2024) 412.14%
Short % of shares outstanding (28 Mar 2024) 410.49%
Shares short (prior month 29 Feb 2024) 47.73M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-46.39%
Return on equity (ttm)-84.44%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -429.14M
Net income avi to common (ttm)-408.17M
Diluted EPS (ttm)-5.73
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)381.82M
Total cash per share (mrq)4.68
Total debt (mrq)30.88M
Total debt/equity (mrq)7.21%
Current ratio (mrq)7.98
Book value per share (mrq)5.28

Cash flow statement

Operating cash flow (ttm)-331.72M
Levered free cash flow (ttm)-213.77M